关注
Michael E. O'Callaghan
Michael E. O'Callaghan
Flinders Medical Centre
在 health.sa.gov.au 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy
G McMichael, MN Bainbridge, E Haan, M Corbett, A Gardner, ...
Molecular psychiatry 20 (2), 176-182, 2015
2452015
Epidemiologic Associations With Cerebral Palsy
ME O'Callaghan, AH MacLennan, CS Gibson, GL McMichael, EA Haan, ...
Obstetrics & Gynecology 118 (3), 576, 2011
1932011
BNC105: a novel tubulin polymerization inhibitor that selectively disrupts tumor vasculature and displays single-agent antitumor efficacy
G Kremmidiotis, AF Leske, TC Lavranos, D Beaumont, J Gasic, A Hall, ...
Molecular cancer therapeutics 9 (6), 1562-1573, 2010
1052010
The genomic basis of cerebral palsy: a HuGE systematic literature review
ME O’Callaghan, AH MacLennan, EA Haan, G Dekker
Human genetics 126 (1), 149-172, 2009
772009
Cesarean delivery and cerebral palsy: a systematic review and meta-analysis
M O’Callaghan, A MacLennan
Obstetrics & Gynecology 122 (6), 1169-1175, 2013
742013
The impact of catheter‐based bladder drainage method on urinary tract infection risk in spinal cord injury and neurogenic bladder: a systematic review
N Kinnear, D Barnett, M O'Callaghan, K Horsell, J Gani, D Hennessey
Neurourology and urodynamics 39 (2), 854-862, 2020
602020
Fetal and Maternal Candidate Single Nucleotide Polymorphism Associations With Cerebral Palsy: A Case-Control Study
ME O’Callaghan, AH MacLennan, CS Gibson, GL McMichael, EA Haan, ...
Pediatrics 129 (2), e414-e423, 2012
492012
DNA from buccal swabs suitable for high-throughput SNP multiplex analysis
GL McMichael, CS Gibson, ME O’Callaghan, PN Goldwater, GA Dekker, ...
Journal of biomolecular techniques: JBT 20 (5), 232, 2009
422009
Cancer risk: Accuracy of literature
M O'Callaghan
Science 347 (6223), 729, 2015
392015
Competing risks in older patients with cancer: a systematic review of geriatric oncology trials
N Burdett, AD Vincent, M O’Callaghan, G Kichenadasse
JNCI: Journal of the National Cancer Institute 110 (8), 825-830, 2018
352018
The inverse relationship between prostate specific antigen (PSA) and obesity
AT Aref, AD Vincent, ME O’Callaghan, SA Martin, PD Sutherland, AJ Hoy, ...
Endocrine-related cancer 25 (11), 933-941, 2018
292018
Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity
ME O'Callaghan, E Raymond, J Campbell, AD Vincent, K Beckmann, ...
Prostate cancer and prostatic diseases 20 (4), 378-388, 2017
292017
Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL
M Ang, B Rajcic, D Foreman, K Moretti, ME O'Callaghan
BJU international 117, 68-75, 2016
272016
Optimum tools for predicting clinical outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity
JM Campbell, E Raymond, ME O'Callaghan, AD Vincent, KR Beckmann, ...
Clinical Genitourinary Cancer 15 (5), e827-e834, 2017
262017
Prostate cancer in men aged less than 50 years at diagnosis
NJ Kinnear, G Kichenadasse, S Plagakis, MEO Callaghan, T Kopsaftis, ...
World Journal of Urology, 1824-4, 2016
252016
Genetic and clinical contributions to cerebral palsy: A multi‐variable analysis
ME O'Callaghan, AH MacLennan, CS Gibson, GL McMichael, EA Haan, ...
Journal of paediatrics and child health 49 (7), 575-581, 2013
252013
A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease
R Ruseckaite, K Beckmann, M O’Callaghan, D Roder, K Moretti, J Millar, ...
BMC cancer 16, 1-11, 2016
242016
Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?
D Lin, M O’Callaghan, R David, A Fuller, R Wells, P Sutherland, ...
BMC urology 20, 1-7, 2020
202020
Prostate cancer detection: A systematic review of urinary biosensors
KM Chan, JM Gleadle, M O’Callaghan, K Vasilev, M MacGregor
Prostate Cancer and Prostatic Diseases 25 (1), 39-46, 2022
192022
Localised prostate cancer in elderly men aged 80–89 years, findings from a population‐based registry
S Vatandoust, G Kichenadasse, M O'Callaghan, AD Vincent, T Kopsaftis, ...
BJU international 121, 48-54, 2018
192018
系统目前无法执行此操作,请稍后再试。
文章 1–20